Y-4

Clinical trials for Y-4 explained in plain language.

Never miss a new study

Get alerted when new Y-4 trials appear

Sign up with your email to follow new studies for Y-4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill combo aims to ease stubborn shingles nerve pain

Symptom relief Recruiting now

This study tests whether a new tablet called Y-4, which combines two drugs (pregabalin and riluzole), can better relieve postherpetic neuralgia—persistent nerve pain after shingles—compared to pregabalin alone. About 160 adults in China will take either Y-4 or pregabalin for 14 w…

Matched conditions: Y-4

Phase: PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Symptom relief

Last updated Jun 27, 2026 12:34 UTC

Y-4

Get alerted when new Y-4 trials appear

New pill combo aims to ease stubborn shingles nerve pain